参考文献/References:
[1] Zheng RS, Zhang SW, Zeng HM, et al. Cancer incidence and mortality in China, 2016[J]. J Natl Cancer Cent, 2022, 2: 1- 9.
[2] 中国抗癌协会肝癌专业委员会.肝动脉灌注化疗治疗肝细胞癌中国专家共识(2021版)[J]. 中华消化外科杂志, 2021, 20:754- 759.
[3] Liu B, Zhu X, Gao S, et al. Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post- transarterial chemoembolization for unresectable hepatocellular carcinoma[J]. J Interv Med, 2019, 2: 91- 96.
[4] Lee MY, Yang MH, Liu JH, et al. Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication[J]. Support Care Cancer, 2007, 15: 89- 93.
[5] 刘思源,郭代红,孔祥豪,等. 201299例住院患者过敏反应自动监测研究及相关药物分析[J]. 中国临床药理学杂志, 2021,37:1436- 1440.
[6] 经碧玲,尤国美,余先萍,等. 肝动脉灌注国产奈达铂致过敏反应的观察及护理[J]. 中国实用护理杂志(中旬版), 2010, 10:59- 60.
[7] 邱国钦,罗鹏飞,陈玉强. 动脉用药多西他赛致严重过敏反应一例[J]. 介入放射学杂志, 2012, 21:60- 61.
[8] Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes[J]. Lancet, 1977, 1: 466- 469.
[9] 付巧英,张 红,谷晓月. 83例奥沙利铂过敏反应患者的临床特征分析及护理对策[J]. 当代医学, 2019, 25:92- 95.
[10] Bhargava P, Gammon D, McCormick MJ. Hypersensitivity and idiosyncratic reactions to oxaliplatin[J]. Cancer, 2004, 100: 211- 212.
[11] Gammon D, Bhargava P, McCormick MJ. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol[J]. Oncologist, 2004, 9: 546- 549.
[12] 张文武. 急诊内科学[M]. 北京:人民卫生出版社, 2001:194- 195.
[13] 朱方勇,陈 颢,花永强,等. 原发性肝癌肝动脉灌注奥沙利铂致过敏反应的临床分析[J]. 肿瘤, 2014, 34:547- 563.
[14] 苏 圆,刘贤铭. 奥沙利铂致过敏反应的文献分析[J]. 中国医院用药评价与分析, 2015, 15:131- 133.
[15] 蔡 强. 奥沙利铂过敏反应临床资料分析[J]. 山东大学学报(医学版), 2011, 49: 149- 152.
[16] 李 敏,钟巧妮,赵 丽,等. 中国患者奥沙利铂过敏反应文献分析[J]. 中国药物警戒, 2020, 17:798- 802.
[17] 薛 静,高 旻,潘 莹,等. 某院奥沙利铂过敏反应临床分析及防治[J]. 中国药物警戒, 2020, 17:361- 365.
[18] 王闫飞,付巧英,陈晓艳,等. 单中心奥沙利铂超敏反应的处理及转归真实世界研究[J]. 中国肿瘤临床, 2020, 47:729- 735.
[19] 廖 莉,文 香,李 芹. 76例药物过敏性休克临床分析[J].重庆医学, 2013, 42:1355- 1356, 1359.
相似文献/References:
[1]邢丽,孙丽霞.肝癌介入治疗术中的护理[J].介入放射学杂志,1997,(02):109.
[2]张彩珍,田巧莲,苏秀琴,等.介入放射治疗中病人的护理[J].介入放射学杂志,1999,(02):54.
[3]王希锐,姜旭,廖顺明,等.泛影葡胺引起急性肾功衰竭致死亡一例[J].介入放射学杂志,1996,(03):129.
[4]何光兰,张丽.经皮冠状动脉支架置入术的护理体会[J].介入放射学杂志,2000,(02):118.
[5]赵东旭,张 磊,姜小庆,等.HAIC是老技术还是新方法——理性看待肝动脉灌注化疗[J].介入放射学杂志,2022,31(01):2.
ZHAO Dongxu,ZHANG Lei,JIANG Xiaoqing,et al.Is HAIC an obsolete technology or a novel therapeutic method? HAIC should be treated rationally[J].journal interventional radiology,2022,31(12):2.
[6]贾中芝,曹 妍,李绍钦.血管内含镍金属植入物过敏反应研究进展 [J].介入放射学杂志,2022,31(03):307.
JIA Zhongzhi,CAO Yan,LI Shaoqin..Advances in the study of allergic reactions to nickel-containing metallic endovascular implants[J].journal interventional radiology,2022,31(12):307.
[7]杨 俊,印 于,张 申,等.HAIC序贯TAE治疗不可切除肝细胞癌的安全性和有效性[J].介入放射学杂志,2023,32(03):229.
YANG Jun,YIN Yu,ZHANG Shen,et al.The safety and efficacy of sequential hepatic arterial infusion chemotherapy and transarterial embolization for unresectable hepatocellular carcinoma[J].journal interventional radiology,2023,32(12):229.